Harmonizing biosecurity oversight for gene synthesis

Nature Biotechnology

Volumn 28, Issue 1, 2010, Pages 20-22

  Fischer, Markus ^a   Maurer, Stephen M ^b  

^a Entelechon GmbH   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; DNA SYNTHESIS; GENE SEQUENCE; GENE SYNTHESIS; HEALTH SERVICE; LETTER; PRIORITY JOURNAL;

BIOTECHNOLOGY; BIOTERRORISM; DNA; GENES; GOVERNMENT REGULATION; HUMANS; SEQUENCE ANALYSIS, DNA; UNITED STATES;

EID: 74049124470     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0110-20     Document Type: Letter

References (10)

1. International Association synthetic Biology. code of conduct for best practices in gene synthesis. (2009).
2. International Gene synthesis consortium. Harmonized screening protocol: gene sequence & customer screening to promote biosecurity. (2009)
3. Department of Health and Human services. screening framework guidance for synthetic double-stranded dnA providers. Fed. Regist. 74, 62319-62327 (2009).
4. National science Advisory Board for Biosecurity. Addressing biosecurity concerns related to the synthesis of select agents. (2006).
5. International Association synthetic Biology. Workshop report: technical solutions for biosecurity in synthetic biology. (2008).
6. Check Hayden, e. Nature 461, 22 (2009).
7. Anonymous. World's top gene synthesis companies establish tough biosecurity screening protocol. (2009).
8. Wadman, M. Us drafts guidelines to screen genes. Nature News (4 december 2009).
9. Maurer, S., Fischer, M., Schwer, H., Stähler, C. & Stähler, P. Working paper: making commercial biology safer: what the gene synthesis industry has learned about screening customers and orders. (2009).
10. Tozzi, J. Watchdogs: shell schemes are on the rise. BusinessWeek.com (5 november 2009).